Surrogate Measures of Extent of Interstitial Lung Disease As Measured By Quantitative Radiographic Analysis in Patients with Systemic Sclerosis.

被引:0
|
作者
Volkmann, Elizabeth [1 ]
Tashkin, Donald [2 ]
Tseng, Chi-hong [1 ]
Hyun, Kim [1 ]
Goldin, Jonathan [1 ]
Clements, Philip J. [3 ]
Furst, Daniel E. [1 ]
Khanna, Dinesh [4 ]
Kleerup, Eric [1 ]
Roth, Michael [1 ]
Elashoff, Robert [2 ]
机构
[1] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA
[2] Univ Calif Los Angeles, Los Angeles, CA USA
[3] Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90024 USA
[4] Univ Michigan Hlth Syst, Ann Arbor, MI USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
2995
引用
收藏
页码:S1309 / S1310
页数:2
相关论文
共 50 条
  • [1] Pulse intravenous cyclophosphamide in the treatment of interstitial lung disease in patients with systemic sclerosis.
    Font, J
    Jimenez, S
    Ramos-Casals, M
    Cervera, R
    Trejo, O
    De la Red, G
    Gil, V
    Garcia-Carrasco, M
    Ingelmo, M
    ARTHRITIS AND RHEUMATISM, 2000, 43 (09): : S318 - S318
  • [2] Proteome Analysis of Bronchoalveolar Lavage Fluid in Interstitial Lung Disease with Systemic Sclerosis.
    Shirahama, R.
    Miyazaki, Y.
    Fujii, Y.
    Tamaoka, M.
    Furuie, M.
    Otani, Y.
    Inase, N.
    Yoshizawa, Y.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
  • [3] The efficacy of immunosuppressive agents for interstitial lung disease in systemic sclerosis.
    Nam, EJ
    Seo, JS
    Cho, JH
    Kim, SU
    Han, SW
    Bae, KS
    Jeon, KN
    Kang, YM
    ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S163 - S163
  • [4] Subclinical Interstitial Lung Disease in Patients with Systemic Sclerosis. A Pilot Study on the Role of Ultrasound
    Reyes-Long, Samuel
    Gutierrez, Marwin
    Clavijo-Cornejo, Denise
    Alfaro-Rodriguez, Alfonso
    Gonzalez-Samano, Karen
    Luis Cortes-Altamirano, Jose
    Munoz-Louis, Roberto
    Cruz-Arenas, Esteban
    Camargo, Katia
    Gonzalez, Fernanda
    Bertolazzi, Chiara
    REUMATOLOGIA CLINICA, 2021, 17 (03): : 144 - 149
  • [5] KL-6 as a marker of interstitial lung disease in patients with juvenile systemic sclerosis.
    Vesely, R
    Massa, M
    De Benedetti, F
    Ravelli, A
    D'Alterio, R
    Vargova, V
    Martini, A
    ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S132 - S132
  • [6] ULTRASOUND MAY DETECT SUBCLINICAL INTERSTITIAL LUNG DISEASE IN SYSTEMIC SCLEROSIS.
    Gutierrez, M.
    Bertolazzi, C.
    Clavijo-Cornejo, D.
    Cruz-Arenas, E.
    Gomez-Quiroz, L. E.
    Salaffi, F.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1037 - 1038
  • [7] Successful treatment with bucillamine for intractable interstitial lung disease in systemic sclerosis.
    Ogawa, T
    Ogawa, K
    Ogura, T
    Akutsu, M
    Saito, E
    ARTHRITIS AND RHEUMATISM, 2000, 43 (09): : S317 - S317
  • [8] ANALYSIS OF A COHORT OF PATIENTS WITH SYSTEMIC SCLEROSIS AND INTERSTITIAL LUNG DISEASE
    Mendez Diaz, L.
    Gil Velez, R. J.
    Madronal Garcia, I.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1588 - 1588
  • [9] THE INFLUENCE OF INTERSTITIAL LUNG DISEASE EXTENT IN PATIENTS WITH SYSTEMIC SCLEROSIS ON THE EFFECTIVENESS OF RITUXIMAB THERAPY
    Koneva, Olga A.
    Desinova, Oxana
    Ovsyannikova, Olga
    Garzanova, Liudmila
    Starovoytova, Mayya
    Ananyeva, Lidia
    CHEST, 2023, 164 (04) : 5475A - 5476A
  • [10] Effects of Mycophenolate Mofetil on Pulmonary Lung Function in Interstitial Lung Disease of Systemic Sclerosis.
    Pham, Michael
    Griffing, W. Leroy
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S742 - S742